Drug Shortage Report for TRILEPTAL 600 MG
Report ID | 128183 |
Drug Identification Number | 02242069 |
Brand name | TRILEPTAL 600 MG |
Common or Proper name | TRILEPTAL FCT 600 MG 5 X 10 |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | OXCARBAZEPINE |
Strength(s) | 600MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 5 X 10 |
ATC code | N03AF |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2020-11-06 |
Actual start date | |
Estimated end date | 2020-11-16 |
Actual end date | 2020-11-19 |
Shortage status | Resolved |
Updated date | 2020-11-20 |
Company comments | Demand increase due to generic backorder. Limited stock available being allocated based on customer profile. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-11-09 | English | Compare |
v2 | 2020-11-09 | French | Compare |
v3 | 2020-11-19 | English | Compare |
v4 | 2020-11-19 | French | Compare |
v5 | 2020-11-20 | English | Compare |
Showing 1 to 5 of 5